International Symposium on Immunology and Biotechnology
ISIB
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest innovations in monoclonal antibody technology, including engineering strategies and therapeutic applications. Discussions will focus on the role of monoclonal antibodies in treating various diseases and their impact on patient outcomes.
SDG 3
SDG 4
This session will highlight cutting-edge approaches in vaccine research and development, emphasizing novel platforms and delivery systems. Participants will engage in discussions on the challenges and successes in creating effective vaccines for infectious diseases and cancer.
SDG 3
SDG 9
This track will delve into the molecular mechanisms underlying immune responses and their implications for disease treatment. Researchers will present findings on signaling pathways, immune cell interactions, and their relevance to therapeutic interventions.
SDG 3
SDG 9
This session will focus on the application of gene editing technologies, such as CRISPR, in the field of immunology. Participants will discuss the potential of these technologies to modify immune responses and develop novel therapies.
SDG 3
SDG 9
This track will examine the therapeutic potential of cytokine modulation in various diseases, including cancer and autoimmune disorders. Researchers will share insights into the challenges of cytokine therapy and strategies for enhancing its efficacy.
SDG 3
SDG 9
This session will explore the role of immunomodulators in regulating immune responses and their applications in clinical settings. Presentations will cover the discovery and development of novel immunomodulatory agents.
SDG 3
SDG 9
This track will highlight the importance of translational research in bridging the gap between basic immunology and clinical applications. Researchers will present case studies demonstrating successful translation of immunological discoveries into therapeutic strategies.
SDG 3
SDG 4
This session will focus on the cellular aspects of the immune system, including T cell and B cell biology. Discussions will encompass recent advancements in cellular therapies and their implications for treating immune-related diseases.
SDG 3
SDG 4
This track will address the identification and validation of biomarkers for immune-related diseases, emphasizing their role in diagnostics and personalized medicine. Researchers will share their findings on novel biomarkers and their clinical relevance.
SDG 3
SDG 9
This session will explore the application of nanotechnology in enhancing immunological research and therapeutic development. Presentations will focus on the design of nanocarriers for targeted drug delivery and their impact on immune responses.
SDG 3
SDG 9
This track will examine the latest advancements in molecular diagnostics for immune-related conditions. Participants will discuss innovative techniques for detecting immune dysfunction and their implications for patient management.
SDG 3
SDG 9